Szu-Chun Yang

15PUBLICATIONS
15CO-AUTHORS
Tumour immunologyEpidemiological modellingScience, technology and engineering curriculum and pedagogyPredictive and prognostic markersEpidemiological methods
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (15)

|Jul 27, 2026
Cost-Effectiveness of First-Line Immunochemotherapy Versus BRAF Plus MEK Inhibitors in BRAFV600E-Mutated Metastatic Lung Cancer.

|Dec 17, 2025
Correction: Cost Effectiveness of Exclusionary EGFR Testing for Taiwanese Patients Newly Diagnosed with Advanced Lung Adenocarcinoma.

Huang-Tz Ou, Jui-Hung Tsai, Yi-Lin Chen

|Jun 13, 2025
Validation of the Test of Adherence to Inhalers (TAI) among Taiwanese Patients with Chronic Obstructive Pulmonary Disease.

Yin-Han Wang, Tsung-Ming Yang, Tien-Pei Fang

|Jan 06, 2025
Cost-effectiveness of lazertinib as first-line treatment in patients with EGFR-mutated advanced lung cancer.

Li-Jung Elizabeth Ku, Jui-Hung Tsai, Li-Jun Chen

|Jan 03, 2025
Cost Effectiveness of Exclusionary EGFR Testing for Taiwanese Patients Newly Diagnosed with Advanced Lung Adenocarcinoma.

Huang-Tz Ou, Jui-Hung Tsai, Yi-Lin Chen

|Oct 24, 2024
Estimating Costs Associated with Adverse Events in Patients with Advanced Lung Cancer.

Chien-Yu Lin, Tzu-I Wu, Szu-Chun Yang

Pageof 3

Frequent Collaborators

4 joint publications

Jung-Der Wang

4 joint publications

Huang-Tzu Ou

3 joint publications

Li-Jun Chen

2 joint publications

Chien-Chung Lin